Stage-specific efficacy of osimertinib in treatment-naïve EGFR-mutant non-small cell lung cancer according to baseline genetic alterations in circulating tumor DNA.

Saved in:
Bibliographic Details
Title: Stage-specific efficacy of osimertinib in treatment-naïve EGFR-mutant non-small cell lung cancer according to baseline genetic alterations in circulating tumor DNA.
Authors: Taniguchi Y; Department of Internal Medicine, NHO Kinki Chuo Chest Medical Center, 1180 Nagasone-cho, Kita-ku, Sakai City, Osaka, 591-8555, Japan. taniguchi.yoshihiko.ny@mail.hosp.go.jp., Tamiya A; Department of Internal Medicine, NHO Kinki Chuo Chest Medical Center, 1180 Nagasone-cho, Kita-ku, Sakai City, Osaka, 591-8555, Japan., Osuga M; Center for Biomedical Sciences, Wakayama Medical University, Wakayama, Japan., Isa SI; Clinical Research Center, NHO Kinki Chuo Chest Medical Center, Sakai, Osaka, Japan., Nakamura K; Department of Respiratory Medicine, NHO Asahikawa Medical Center, Asahikawa, Hokkaido, Japan., Mizumori Y; Department of Respiratory Medicine, NHO Himeji Medical Center, Himeji, Hyogo, Japan., Shinohara T; Department of Respiratory Medicine, NHO Kochi Hospital, Kochi, Japan., Yanai H; Department of Respiratory Medicine, NHO Mito Medical Center, Ibaraki, Japan., Nakatomi K; Department of Respiratory Medicine, NHO Ureshino Medical Center, Ureshino, Saga, Japan., Oki M; Department of Respiratory Medicine, NHO Nagoya Medical Center, Nagoya, Aichi, Japan., Mori M; Department of Thoracic Oncology, NHO Osaka Toneyama Medical Center, Toyonaka, Osaka, Japan., Kuwako T; Department of Respiratory Medicine, NHO Shibukawa Medical Center, Shibukawa, Gunma, Japan., Yamazaki K; Department of Thoracic Surgery, NHO Kyushu Medical Center, Fukuoka, Kyushu, Japan., Shimada M; Department of Respiratory Medicine, NHO Tokyo National Hospital, Tokyo, Japan., Ando M; Department of Advanced Medicine, Nagoya University Hospital, Aichi, Japan., Koh Y; Center for Biomedical Sciences, Wakayama Medical University, Wakayama, Japan.; Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
Source: Investigational new drugs [Invest New Drugs] 2025 Feb; Vol. 43 (1), pp. 101-107. Date of Electronic Publication: 2025 Jan 09.
Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1573-0646
DOI:10.1007/s10637-024-01500-9